NMJ, Muscle: MG, LES, DMD/BMD, MD, GBS, MND, Botulism, Tetanus Flashcards

1
Q

MG
-epidemiology
-pathophysiology
-presentation

A

Not common
-young women, older men

AI -ACh rec AB => muscle contraction reduced
Gradual/rapid onset after illness, stress, pregnancy

Fatiguable, painless muscle weakness that improves with rest
-eyes, eyelid, facial, speech muscles
-limbs, resp muscles
No impact on GU, heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MG
-investigations, diagnosis

A

Blood
-AChR - negative does not rule out possibility
-MuSK AB
-high association with other AI (T1DM, thyroiditis)

Imaging
-thymus hyperplasia - overactivity
-thymoma => rarely malignant but removed eventually

Diagnostic - rep EMG stimulation
-decreased amplitude over time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MG
-management

A

Lifestyle - avoid triggers
-sufficient rest, stress reduction
-flu/pneumonia jab

Symptomatic - pyridostigmine (AChesterase inh)

Immune system control - CS (induce remission, taper down eventually)
2nd line - DMARD (Aza, metho)

Crisis - breathing and swallowing problems => ICU resp support, plasmapheresis, IVIG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

LES
-pathophysiology
-presentation

A

AI AB against presynaptic VGCC in PNS

Repeated muscle contractions => increased muscle strength
-limb girdle weakness (mainly in legs)
Autonomic involvement - urination/defecation issues, impotence
Hyporeflexia

Eye symptoms not a feature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

LES
-investigations

A

EMG => incremental response to repetitive electrical stimulation

Autoantibody electrical stimulation

Chest CT - small cell lung cancer association

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

LES
-management

A

SCLL management

AChinh or aminopyridines (block K channels => increases Ca influx) - diaminopyridine/pyridostigmine
Severe - CS +DMARD (pred + aza)

Plasmapheresis
IVIG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Polymyositis and dermatomyositis
-pathophysiology, presentation
-epidemiology

A

Inflammatory => symmetrical proximal muscle weakness
-tender
-resp muscle weakness, IDL
-dysphagia, dysphonia
-Raynauds

P - no skin signs
D - heliotrope rash on cheeks, eyelids
-photosensitivity
-red papules over finger extensors
-dry, scaly, cracked hands on palmar
-nailfold capillaries

Middle age females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Polymyositis, dermatomyositis
-investigations
-management

A

High CK
-other muscle enzymes high (LDH, aldolase, AST, ALT)
AB - more specific
P - anti Jo
D - anti Mi

EMG

Definitive - muscle biopsy

Definitive - pred
Supportive - sun protection, exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

DMD and BMD
-pathophysiology
-presentation

A

X recessive - mutated dystrophin gene
-needed to connect muscle membrane to actin

DMD - frameshift => severe
BMD - non frameshift => milder form

DMD
-progressive proximal muscle weakness
-calf pseudohypertrophy
-Gowers sign - arms needed to stand up
-Waddling gait
-loss of walk by 12
-intellectual impairment common

BMD
-10y/o+
-intellectual impairment less common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

DMD and BMD
-investigations
-management

A

High CK -released in muscle damage
Definitive - molecular diagnosis

1st line - CS
-Improve motor and lung function
-delay loss of ambulation, cardiomyopathy

Physio, OT input

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Myotonic dystrophy
-epidemiology, pathophysiology
-presentation

A

Inherited AD myopathy - 20-30 y/o
Affects skeletal, cardiac, smooth muscle

Myotonic dystrophy - contracted muscle destruction
-frontal balding
-arrythmias
-early cataracts
-DM

DM1 - distal weakness
DM2 - proximal weakness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Myotonic dystrophy
-investigations
-management

A

Definitive - genetics
-DM1 CTG repeat C19
-DM2 repeat expansion C3

No cure, focus on managing symptoms

Physio - maintain strength and endurance, control MSK pain
OT - canes, braces, walkers

Symptomatic management
-arrythmias
-cataracts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

GBS
-presentation
-pathophysiology

A

Adults, males
Immune mediated attack on Schwann cells in PNS
-often triggered by infection - campylobacter jejuni

Leg, back pain => progressive ascending symmetrical weakness of all limbs
More motor than sensory loss
Reduced reflexes

Resp muscle weakness
Urinary retention, constipation
Diplopia
Bilateral facial palsy
Dysphagia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

GBS
-investigations, diagnosis
-management

A

Definitive
-nerve conduction - demyelination => slow conduction
-lumbar puncture - normal WCC, high protein

ABG - resp acidosis
Spirometer - restrictive (muscle weakness)
-May require ventilation

IVIG - stop harmful AB from causing further damage
Plasmapheresis
Resp failure support

Complete recovery in 1 year
-long term rehab needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

GBS differentials
-timeframe and management

A

Chronic inflammatory demyelinating polyneuropathy
-AB mediated inflammation => demyelination of peripheries
-insidious onset over months
-treated with IC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Investigations used for suspected muscle conditions

A

EMG neurophysiology - good to rule out other neuropathies

Muscle biopsy analysis - immunohistology, staining

MRI muscle

DNA analysis - gold standard for direct mutation detection

17
Q

MND
-presentation
-investigations
-management

A

60-70s males

LMN and UMN
-fasciculations
-wasting of intrinsic hand muscles, tibialis anterior (foot drop, high steppage gait)
-eye sparing
-no cerebellar, sensory signs

Clinical diagnosis
EMG - reduced action potentials with increased amplitude

Riluzole
Respiratory care
-NIV BIPAP used at night

18
Q

Botulism
-causative organism
-pathophysiology
-presentation
-investigations
-management

A

Clostridium botulinum => neurotoxin blocks ACh release at NMJ
Affects bulbar muscles and ANS

Contaminated food
IVDU

No sensory disturbance
Flaccid paralysis
Diplopia
Ataxia
Bulbar palsy - dysphagia, dysphonia, dysarthria

Clinical diagnosis

Botulinum antitoxin - only works if given early, toxin binding is irreversible
Supportive care

19
Q

Tetanus
-causative organism
-pathophysiology
-presentation
-investigations
-management

A

Clostridium tetani - exotoxin prevents release of GABA => spreads and affects CNS

Soil
IVDU

Prodrome - fever, lethargy, headache
Lockjaw, risus sardonicus
Opisthotonus - arched back, hyperextended neck
Spasms

Clinical diagnosis

Supportive - ventilatory support, muscle relaxants
IM tetanus IG for high risk wounds
Metronidazole

20
Q

Tetanus vaccination
-type
-when is it given
-wound classification
-management of injuries

A

Toxin
-2, 3, 4 months
-3, 5, 13-18 years

Clean - U6hrs old, non penetrating, minimal damage

Tetanus prone
-puncture wound in contaminated environment
-foreign body contamination
-compound fracture
-wounds, burns with systemic sepsis
-animal bites and scratches

High risk
-heavy contamination with soil
-wounds or burns with extensive devitalised tissue
-wounds or burns needing surgical intervention

Full course + last dose U10 years ago => no vaccine or IG needed

Full course + last dose 10+ years ago
Tetanus prone => vaccine
High risk => vaccine + IG

Vaccination Hx unknown/uincomplete => vaccine
Tetanus prone/high risk => add IG